Patents by Inventor Hans E.J. Hofland

Hans E.J. Hofland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Topical Compositions Comprising IRAK4 Inhibitors for Use in Treating Dermatological Conditions Characterised by Inflammation
    Publication number: 20230125380
    Abstract: This disclosure is directed to use of IRAK4 inhibitors in the treatment of dermatological disorders or conditions characterized by inflammation This disclosure is also directed to pharmaceutical compositions comprising an IRAK4 inhibitor and a pharmaceutically acceptable carrier for topical administration
    Type: Application
    Filed: November 5, 2020
    Publication date: April 27, 2023
    Inventors: Jamie L. Harden, Hans E.J. Hofland
  • ROR Gamma T Inhibitors and Topical Uses Thereof
    Publication number: 20220409643
    Abstract: The present disclosure is directed to use of ROR?t inhibitors in the treatment of autoimmune disorders, e.g., autoimmune disorders of the skin. This disclosure is also directed to pharmaceutical compositions comprising an ROR?t inhibitor and a pharmaceutically acceptable carrier for topical administration.
    Type: Application
    Filed: November 5, 2020
    Publication date: December 29, 2022
    Inventors: Jamie L. Harden, Hans E.J. Hofland
  • METHODS FOR PALMAR OR PLANTAR ADMINISTRATION OF PHARMACEUTICAL COMPOSITIONS
    Publication number: 20220401412
    Abstract: Disclosed herein are methods for palmar or plantar administration of anticholinergic compounds to a subject in need thereof. Also disclosed herein are methods of treating palmar or plantar hyperhidrosis in a subject in need thereof by administering anticholinergic compounds to the palmar or plantar skin of the subject.
    Type: Application
    Filed: November 4, 2020
    Publication date: December 22, 2022
    Inventors: Hans E.J. HOFLAND, Janice S. DREW
  • LIPOSOMAL L-CARNITINE
    Publication number: 20090196914
    Abstract: The present invention provides liposomal L-carnitine formulations and methods for the treatment of intermittent claudication. The formulation is optimized with respect to L-carnitine transport through skin in vitro. Preferably, the formulation is a topical cream for the administration of the drug directly on the muscle group that is most affected by the poor local blood flow.
    Type: Application
    Filed: July 23, 2008
    Publication date: August 6, 2009
    Applicant: OPTIME Therapeutics, Inc.
    Inventor: Hans E.J. Hofland